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Isolated patellofemoral osteoarthritis (PF-OA) predominantly 
affects women, the elderly, and young adults with dysplasia 
or former trauma. 11% of male patients and 24% of female 
patients with symptomatic knees have PF-OA (McAlindon et 
al. 1992) and could therefore be candidates for patellofemoral 
arthroplasty (PFA). 
Controversy concerning PFA has led surgeons to choose 
total knee arthroplasty (TKA) in patients with PF-OA. Recent 
studies on PFA show good results, however, with high sur-
vival rates and satisfying patient-reported outcomes (Goh et 
al. 2015, Halai et al. 2016, Konan and Haddad 2016, Osarum-
wense et al. 2017, Odgaard et al. 2018), suggesting that PFA 
may be a good choice in suitably selected patients. A rise in 
PFA operations has been seen in Denmark from 0.6% of pri-
mary arthroplasties in 2012, to 1.3% in 2016, but the reported 
prevalence of PF-OA (McAlindon et al. 1992) suggests that 
PFA is under-used. Register studies show poor survival of 
PFA compared with TKA where the 2-year survival is 91% 
and 97% and 10-year survival is 73% and 93%, respectively 
(Odgaard et al. 2017).
Because of this controversy, we performed a systemic 
review with the following purposes: (1) to investigate the 
reasons for revisions of PFA, (2) to highlight possible differ-
ences in data from registries and protocolled studies, and (3) 
describe differences in failure modes among implant designs.
Van der List et al. (2017) published a similar review. In 
our review we present newer results, a higher number of revi-
sions (1,299 vs. 938), and, as van der List et al. suggested, 
we investigate the impact of implant design on failure modes. 
Furthermore, we focus on the differences between data from 
registries and protocolled studies.
Background and purpose — Patellofemoral arthroplasty 
(PFA) has been debated since early studies showed poor 
implant survival. Recent studies show better results. This 
review reports failure modes for PFA and investigates dif-
ferences in data reported from registries and clinical studies. 
Additionally, we report differences in failure modes among 
implant designs.
Methods — A systematic search was performed in Sep-
tember 2018. All studies and registers describing failure 
modes of PFA were included and implant design was noted 
for each revision.
Results — This review includes 1,299 revisions of a pri-
mary PFA reported in 47 clinical studies and 3 registers. The 
failure modes were: 42% OA progression, 16% pain, 13% 
aseptic loosening, 12% surgical error, 4% wear, 2% infec-
tion, 2% broken patellar component, 1% stiffness, 1% frac-
ture, and 7% other. The data from registries and cohort stud-
ies differed statistically significantly in 7 out of 12 failure 
modes. Significant differences were found in several failure 
modes among implant designs.
Interpretation — OA progression is the most common 
failure mode of PFA. There are significant differences in 
data on failure modes between registers and protocolled 
studies, notably for surgical error. The implant design sig-
nificantly influences several of the failure modes. In conclu-
sion, indication, surgical technique, and implant design are 
important for a successful PFA, and register-based failure 
modes should be interpreted with caution.
474 Acta Orthopaedica 2019; 90 (5): 473–478
Methods
Search strategy
A systematic search was performed in September 2018. 
Electronic databases (PubMed, Embase, and Cochrane 
Library) were searched with the terms “arthroplasty AND 
(patellofemoral OR PF OR PFA OR PFR) AND (outcome 
OR functional outcome OR scores OR results OR revision 
OR revision rate OR reoperation OR treatment failure OR 
prosthesis failure OR failure OR failure rate OR survivor-
ship OR survival).” 
16 additional articles included in the protocol for the RCT 
study of Odgaard et al. (2018) were used for a cited reference 
search (Arciero and Toomey 1988, Grelsamer 1990, Argen-
son et al. 1995, Krajca-Radcliffe and Coker 1996, Tauro et 
al. 2001, De Winter et al. 2001, Smith et al. 2002, Kooijman 
et al. 2003, Merchant 2004, Board et al. 2004, Ackroyd and 
Chir 2005, Argenson et al. 2005, Blazina et al. 2005, Cartier et 
al. 2005, Ackroyd et al. 2007, Merchant et al. 2017). Articles 
were selected by relevance and had to be registered on Web 
of Science. 
NBB and PWE scanned titles and abstracts for relevance, 
and full texts were evaluated against the eligibility criteria. 
Included articles were checked for eligibility by AO. Studies 
found during the search were screened for any further stud-
ies containing relevant data. Final consensus on inclusion was 
reached between the authors. 
Finally, registries from Scandinavia, England/Wales, The 
Netherlands, New Zealand and Australia were screened for 
information, last accessed on December 17, 2018. 
The review was conducted in accordance with 
PRISMA guidelines and is registered on PROSPERO 
(CRD42018115774).
Inclusion criteria
All studies reporting reasons for revision of PFA were 
included. A revision was defined as surgery where single or 
multiple components of the implant were removed, replaced, 
or supplemented. Studies in languages other than English 
were included if data was extractable by the authors.
Exclusion criteria
Studies using the same cohort or database as in an already 
included study were excluded to eliminate the risk of patients 
being counted repeatedly.
Data collection
Parameters included: authors, year published, year cohort 
started/ended, mean years of follow-up, number of arthro-
plasties, number of revisions, type of implant, and reasons 
for revision. 26 different failure modes were identified. These 
were categorized into 12 groups (Table 1, see Supplementary 
data).
Quality of studies
All studies were assessed for quality by NBB and PWE 
according to Grading quality of evidence and strength of rec-
ommendations (GRADE).
Statistics
A pooled analysis was performed for each failure mode. Final 
groups of failure modes were presented in percentages. A 
chi-square test was performed in accordance to outcomes: (1) 
Failure modes in cohorts vs. registries and (2) Failure modes 
between each implant design vs. all others. In samples where 
expected frequencies were lower than five, Fisher’s exact test 
was used. P-values < 0.05 were considered significant. All 
statistical analyses were performed in Excel 2016 (Microsoft 
Corp., Redmond, WA, USA).
Funding and potential conflicts of interest
Institutional support was received from Stryker European 
Operations BV for studies on patellofemoral implants. 
Stryker had no influence on data accumulation, analysis or 
interpretation.
Results (Tables 2–8, see Supplementary data)
Search results
The primary search identified 2,522 studies and 17 additional 
studies were located by the cited reference search and by 
screening of references. 1,344 unique articles were found, and 
1,217 articles were excluded during the screening of titles and 
abstracts. 127 articles were assessed for eligibility, and 50 arti-
cles (3 registers and 47 clinical studies) were included (Figure). 
Only the New Zealand, Australian, and English registry had 

















Full-text articles excluded (n = 77):
– no description of failure modes, 58
– same cohort as another study/register, 15
– no quantitative data on failure modes, 4 
Flowchart.
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(Muir et al. 1999, Baker et al. 2012, Australian Orthopaedic 
Association 2017)
Quality of studies
The search revealed 1 level I RCT study, 31 level II prospec-
tive cohort studies, 14 level III–IV observational studies, and 
1 level VI case study (Table 3). The studies were published 
between 1996 and 2018. Heterogeneity existed in the follow-
up periods and types of implants used. The quality of evidence 
was, according to GRADE guidelines, low. 
Failure modes of the patellofemoral implant 
47 clinical studies and 3 registers containing 1,299 revisions 
of PFAs were found. The most common failure modes were 
OA progression (42%), pain (16%), aseptic loosening (13%), 
and surgical error (12%). Failure modes varied among regis-
tries (Table 2).
Registries vs. clinical studies
Statistically significant differences were found between regis-
ters and clinical studies in 7 out of 12 failure modes (Table 4). 
Pain, aseptic loosening, operational flaws, and broken patellar 
component were all found to be highly significant (p < 0.001). 
Additionally, significant differences were observed with pro-
gression of OA and infection (p = 0.009 and p = 0.04, respec-
tively). 
Pain and aseptic loosening were more often reported as indi-
cation for revision in registers (20% vs. 10% and 17% vs. 7%, 
respectively). In clinical studies, progression of OA and surgi-
cal errors were more dominant than in registers (48% vs. 38% 
and 21% vs. 7%, respectively) (Table 4).
Failure modes and implant design
40 studies reported data on specific implants (Table 5). 7 stud-
ies did not relate cause for revision and implant design and 
were excluded in this outcome. 64 revisions were excluded 
from clinical studies, and all 807 revisions from registers were 
excluded in the same manner. 428 revisions were included 
(Table 5) and chi-square and Fisher’s tests were performed on 
these. 5 implant designs (Avon, Richards, Lubinus, Autocen-
tric, and LCS) had more than 30 documented revisions, and 
these were chosen for further analysis (Tables 5 and 6).
The Avon implant was revised more often (p = 0.02) for OA 
progression with relative risk (RR)  = 1.4, and less for surgical 
errors (p = 0.001) with RR = 0.2. The Richards design was, 
with RR = 0.8, revised less for pain (p = 0.007). The Lubinus 
design was more often revised because of surgical errors (p 
< 0.001) with RR = 3.9 and wear (p = 0.001), RR = 4.3, and 
less often for OA progression (p = 0.005) RR = 0.5, pain (p 
= 0.03) RR = 0.2, and none for aseptic loosening (p = 0.008). 
The Autocentric implant had a higher incidence of aseptic 
loosening (p < 0.001), RR = 4.9, infection (p = 0.007), RR = 
14 and was the only design with stiffness as a failure mode (p 
< 0.001), while 0 was revised because of pain (p = 0.04). The 
LCS implant had a greater revision rate for pain (p < 0.001) 
RR = 5.5 and surgical errors (p = 0.002), while progression of 
OA (p < 0.001) was seen less frequently with RR = 0.2.
Discussion
Progression of osteoarthritis as the main failure mode
This review found the most frequently reported reason for 
revision of PFA to be OA progression with a proportion of 
42% (48% in studies and 38% in registries). Because some 
revised knees in this group may have been reported with the 
nonspecific failure mode of pain, this could even be an under-
estimation. Progression of OA can be viewed in 2 ways: (1) as 
a victory for the implant in long-term follow-up studies since 
it survived implant-dependent failure modes, and (2) as poor 
patient selection in studies with short-term follow-up.
When deciding between PFA and TKA, strict patient selec-
tion is suggested (Mohammed et al. 2008, Goh et al. 2015, 
Odgaard et al. 2017). Patients having a PFA for primary OA 
may have a higher incidence of progression of TF-OA com-
pared with patients having surgery for dysplasia or previous 
fracture (Smith et al. 2002, Argenson et al. 2005). Progression 
of TF-OA has been noted mainly in patients with malalign-
ment compared with a neutral hip–knee–ankle angle (Cartier 
et al. 2005). Studies including patients with TF-OA (Leadbet-
ter et al. 2009, Williams et al. 2013, Dahm et al. 2014) reported 
a higher incidence (75%) of patients revised because of OA 
progression. These findings support the importance of strict 
patient selection. To identify patients with isolated PF-OA, 
Cartier et al. (2005) claimed that medial knee pain ascending 
stairs always indicates PF-OA, and pain descending stairs is 
of TF-OA origin. Bone-on-bone on tangential (skyline) radio-
graphs is the deciding radiographic proof of PF-OA (Odgaard 
et al. 2017, Cuthbert et al. 2018). We encourage thorough 
clinical and imaging investigations preoperatively, and stress 
radiography, specialized radiographic projections, and MRI 
should be considered to ensure the absence of TF-OA.
Odgaard et al. (2018) published early results of a double-
blinded RCT comparing PFA and TKA for isolated PF-OA. 
They concluded that patients treated with PFA obtained better 
knee function, better satisfaction, and larger knee-related 
quality of life compared with TKA within the first 2 years. 
The study found similar short-term survival rates for the 2 
implants. Cartier et al. (2005) reported no complications in 
getting back to daily activities and sports after PFA surgery. 
Additionally, studies show that revision of PFA to TKA does 
not present any particular difficulties (van Jonbergen et al. 
2009, Parratte et al. 2015). Therefore, it could be argued that 
PFA should have a place in the treatment of knee OA as a 
temporary implant towards TKA (Argenson et al. 2005, Lead-
better et al. 2009). Using the implant as a stepping stone could 
give the patient some years with a higher knee-related qual-
ity of life without compromising the results of a future TKA. 
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However, a recent study on a cohort from the Australian regis-
try shows that the risk of re-revision of a secondary TKA from 
a PFA is larger than the risk of a revision of a primary TKA 
(Parker et al. 2019), but the extent of confounding in regis-
ter studies is unknown. Only longitudinal protocolled studies 
with time-weighted outcomes, e.g., area under the curve for 
PRO data, can determine the better strategy.
In line with results published by van der List et al. (2017) 
we found that progression of OA is the key failure mode for 
PFA. Our data, however, show a lower rate of OA progression 
(42% vs. 49%) and a higher rate of pain (16% vs. 6%), which 
indicates that the 2 populations differ. This review consists of 
newer data and a larger population.
Registries vs. clinical studies
In 7 of 12 failure modes, we found a statistically significant dif-
ference between register and cohort studies (Table 4). The dif-
ference may be explained by the way indications for revisions 
are recorded. Where registries use fixed modes of failure, stud-
ies tend to record more specific indications. Register data (Muir 
et al. 1999, Baker et al. 2012, Australian Orthopaedic Associa-
tion 2017) are almost devoid of surgical errors and have a high 
rate of pain as indication, suggesting that surgeons have a pref-
erence for reporting the nonspecific symptom rather than surgi-
cal errors. It may reasonably be assumed that surgeons have a 
higher tendency to scrutinize indications for patients included in 
a clinical study. The variation in failure modes among registers 
suggests that registration practice or indications vary. Cohort 
studies (e.g. van Jonbergen et al. 2010) investigate a specific 
implant, its survival, and its failure modes. They report a high 
rate of OA progression, surgical error, and wear. No patients 
were revised by the nonspecific indication pain, suggesting that 
focus on diagnostics could be different in cohort studies vs. the 
daily registration for registers. 
Van der List et al. (2017) reported OA progression as the 
most common failure mode with more than 5 years’ follow-up. 
Most clinical studies included in our review have a short fol-
low-up, and therefore include a large proportion of early revi-
sions. The included registries date back to 1999–2003 and have 
no defined end follow-up. Therefore, it would be expected that 
registries would contain a larger proportion of revisions with 
more than 5 years’ follow-up and therefore a higher proportion 
of OA progression. The conflict between this expectation and 
actual register data supports the argument that revisions are 
reported with the less specific indication of pain.
The year of operation could influence the cause for revision. 
Our cohorts report data back to 1972 (Argenson et al. 2005), 
and the earliest registries start in 1999 (Muir et al. 1999, Aus-
tralian Orthopaedic Association 2017). The high rate of surgi-
cal errors in the studies could be caused by early, less success-
ful implant designs. An example is the Lubinus implant where 
Tauro et al. (2001), in a cohort from 1989–1995, reported a 
71% failure by maltracking and called the implant “Unforgiv-
ing.” They even converted the trochlear component later in 
their study, using the left component on the right knee and 
vice versa.
The review by van der List et al. (2017) reports the same 
incoherence between registries and studies. The only differ-
ence in data is infection, which in our review is more often 
reported from registries. 
Failure modes and implant design
OA progression may be a success criterion for the implant 
design or suggest poor patient selection. A high percentage of 
revisions for OA progression in cohort studies with a long fol-
low-up period (> 10 years) suggests a satisfactory design. This 
was observed in the study by Kooijman et al. (2003), where 
the Richards II design has a 75% failure by OA progression, 
and in the cohort from Nicol et al. (2006) who reported an 
80% failure by this mode with the Avon design.  
With a 56% rate of surgical error as failure mode (Table 6), 
the Lubinus design has met with controversies. More authors 
have questioned the anatomical design of the femoral compo-
nent and agree that a non-anatomical design such as Avon or 
Richards is preferable (Tauro et al. 2001, Board et al. 2004, 
Cartier et al. 2005). Tauro et al. argue that the anatomical and 
asymmetrical design of the femoral groove in the component 
impairs the surgeon’s ability to correct an existing anatomical 
dysplasia with maltracking.
The results of LCS and Autocentric (Table 6) may indicate 
constructional flaws. The mobile bearing LCS design has a 
metal-backed patellar component (Charalambous et al. 2011). 
Yadav et al. (2012) argue that rotational freedom of the poly-
ethylene could lead to locking in the trochlear groove and 
may cause mechanical problems and wear. Charalambous et 
al. (2011) found overgrowth of soft tissue in several of their 
revisions, resulting in a blocking of the rotation of the poly-
ethylene, which may have caused the high frequency of pain 
in their study. Furthermore, extensive metallosis was found 
in 3 of 17 revised knees, likely caused by the metal-backed 
patella. Because of non-satisfactory results, Australia stopped 
using the LCS implant in 2009 (Australian Orthopaedic Asso-
ciation 2017). In studies concerning the Autocentric implant, 
aseptic loosening was the dominant failure mode (Table 6) 
(De Cloedt et al. 1999, Argenson et al. 2005), which may give 
the impression of design problems. 
Limitations and bias 
This study has several limitations, mainly the problem of 
inclusion. We strove to include as many revisions as possible, 
even a revision from a biased case study reporting only a single 
failure mode. On these grounds we cannot exclude confound-
ers and bias in general. To ensure that data of a cohort are 
only used once, we had to exclude some studies knowing that 
we lost data. It was not possible to detect duplicates between 
registries and studies, so this is also a bias in our study. 
This review’s first outcome has similarity to the article pub-
lished by van der List et al. (2017), but some inconsistencies 
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were found with inclusion of patients and extraction of data in 
their paper. An example is data from Kooijman et al. (2003) 
where data on 19 revisions were extracted, but only 10 of 
these fulfilled their definition of revision, which was conver-
sion to a TKA.
Conclusion
Progression of TF-OA is the most common failure mode of 
PFA. The data from registries and cohort studies differ signifi-
cantly in several modes of failure, notably for surgical error. 
The implant design has a significant influence on several of 
the failure modes. In conclusion, indication, surgical tech-
nique, and implant design are important for a successful PFA.
Supplementary data
Tables 1–8 are available as supplementary data in the online 
version of this article, http://dx.doi.org/10.1080/17453674. 
2019.1634865
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